2-1494031-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001206744.2(TPO):​c.1998C>T​(p.Asp666Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.366 in 1,613,066 control chromosomes in the GnomAD database, including 108,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 9970 hom., cov: 32)
Exomes 𝑓: 0.37 ( 98914 hom. )

Consequence

TPO
NM_001206744.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -5.14

Publications

30 publications found
Variant links:
Genes affected
TPO (HGNC:12015): (thyroid peroxidase) This gene encodes a membrane-bound glycoprotein. The encoded protein acts as an enzyme and plays a central role in thyroid gland function. The protein functions in the iodination of tyrosine residues in thyroglobulin and phenoxy-ester formation between pairs of iodinated tyrosines to generate the thyroid hormones, thyroxine and triiodothyronine. Mutations in this gene are associated with several disorders of thyroid hormonogenesis, including congenital hypothyroidism, congenital goiter, and thyroid hormone organification defect IIA. Multiple transcript variants encoding distinct isoforms have been identified for this gene, but the full-length nature of some variants has not been determined. [provided by RefSeq, May 2011]
TPO Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 2A
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.039).
BP6
Variant 2-1494031-C-T is Benign according to our data. Variant chr2-1494031-C-T is described in ClinVar as Benign. ClinVar VariationId is 256608.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TPONM_001206744.2 linkc.1998C>T p.Asp666Asp synonymous_variant Exon 11 of 17 ENST00000329066.9 NP_001193673.1 P07202-1Q502Y3Q6P534

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TPOENST00000329066.9 linkc.1998C>T p.Asp666Asp synonymous_variant Exon 11 of 17 1 NM_001206744.2 ENSP00000329869.4 P07202-1

Frequencies

GnomAD3 genomes
AF:
0.361
AC:
54843
AN:
151852
Hom.:
9964
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.327
Gnomad AMI
AF:
0.390
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.359
Gnomad EAS
AF:
0.415
Gnomad SAS
AF:
0.367
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.365
Gnomad OTH
AF:
0.370
GnomAD2 exomes
AF:
0.368
AC:
92063
AN:
250454
AF XY:
0.367
show subpopulations
Gnomad AFR exome
AF:
0.321
Gnomad AMR exome
AF:
0.387
Gnomad ASJ exome
AF:
0.350
Gnomad EAS exome
AF:
0.411
Gnomad FIN exome
AF:
0.371
Gnomad NFE exome
AF:
0.360
Gnomad OTH exome
AF:
0.365
GnomAD4 exome
AF:
0.367
AC:
535807
AN:
1461098
Hom.:
98914
Cov.:
42
AF XY:
0.367
AC XY:
266775
AN XY:
726928
show subpopulations
African (AFR)
AF:
0.329
AC:
11023
AN:
33472
American (AMR)
AF:
0.385
AC:
17233
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.351
AC:
9171
AN:
26132
East Asian (EAS)
AF:
0.449
AC:
17838
AN:
39696
South Asian (SAS)
AF:
0.376
AC:
32437
AN:
86236
European-Finnish (FIN)
AF:
0.371
AC:
19761
AN:
53326
Middle Eastern (MID)
AF:
0.342
AC:
1973
AN:
5766
European-Non Finnish (NFE)
AF:
0.364
AC:
403999
AN:
1111402
Other (OTH)
AF:
0.371
AC:
22372
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
20195
40390
60586
80781
100976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12872
25744
38616
51488
64360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.361
AC:
54876
AN:
151968
Hom.:
9970
Cov.:
32
AF XY:
0.362
AC XY:
26900
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.327
AC:
13570
AN:
41468
American (AMR)
AF:
0.404
AC:
6171
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
1245
AN:
3472
East Asian (EAS)
AF:
0.415
AC:
2133
AN:
5136
South Asian (SAS)
AF:
0.366
AC:
1760
AN:
4804
European-Finnish (FIN)
AF:
0.373
AC:
3937
AN:
10566
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.365
AC:
24827
AN:
67938
Other (OTH)
AF:
0.368
AC:
778
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1812
3624
5436
7248
9060
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.360
Hom.:
21570
Bravo
AF:
0.360
Asia WGS
AF:
0.382
AC:
1327
AN:
3478
EpiCase
AF:
0.368
EpiControl
AF:
0.360

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deficiency of iodide peroxidase Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.18
DANN
Benign
0.35
PhyloP100
-5.1
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1126797; hg19: chr2-1497803; COSMIC: COSV61102057; API